Brent Dover is the CEO of Carta Healthcare, an AI-powered clinical data management platform that serves hospitals and health systems nationwide using a 'Hybrid Intelligence' model combining AI with human expert abstractors. With over 20 years of healthcare technology leadership, Dover has presided over company-defining exits and growth events - including leading Medicity to a $500M acquisition by Aetna generating 16x investor returns, scaling Health Catalyst toward a NASDAQ IPO, and growing Commure to a $3.5B valuation. He joined Carta Healthcare in December 2023 and has since driven 2x revenue growth, 100% customer retention, and a $18.25M Series B1 round led by UPMC Enterprises.
Karim Karti is the CEO of RapidAI, a deep clinical AI company whose platform is used in 2,500+ hospitals across 100+ countries for stroke, vascular, and radiology workflows. He brings 22+ years from GE Healthcare — including running its $9B imaging division — and a stint as COO of iRhythm, where he doubled revenues to $210M in 18 months. Trained as an engineer in France and a former P&G brand manager, he now leads one of the most clinically validated AI platforms in medicine, backed by 700+ published studies and 10+ million scans processed.
Punit Singh Soni is the founder and CEO of Suki, the ambient clinical intelligence platform that lets doctors spend more time with patients and less time typing into electronic health records. A product veteran who helped ship the Moto X and rebuild Flipkart's consumer experience, Soni founded Suki in 2017 on a single thesis - 'AI is the new UI' - before that phrase became a conference staple. Suki now serves 350+ health systems across the US, has raised $255 million in total funding, and helps clinicians complete notes 72% faster. Soni was educated at NIT Kurukshetra, the University of Wyoming, and Wharton, and has lived at the intersection of big tech, emerging markets, and healthcare for over two decades.
Rad AI builds generative-AI software that drafts the most tedious parts of a radiology report - the impressions, the follow-ups, the boilerplate - so radiologists can spend more time on the images and less on the keyboard. Founded in 2018 by a radiologist (Jeff Chang) and a serial founder (Doktor Gurson), the company now works with roughly nine of the ten largest radiology groups in the U.S. and touches close to half of the country's medical imaging.
RapidAI builds FDA-cleared clinical AI software that reads CT, CTA, CT perfusion and MRI scans to flag stroke, aneurysms and pulmonary embolisms in minutes - giving hospital teams a faster path to treatment. The platform began life as the Stanford spin-out iSchemaView and now runs in more than 2,000 hospitals across 100+ countries.
Chris Mansi is a Cambridge and UCL-trained neurosurgeon turned AI entrepreneur, and the Co-founder and CEO of Viz.ai - the company that puts an AI brain between a CT scanner and a surgeon so that patients who are about to die of a stroke stop dying from delays. Named to TIME100 AI in 2024, Mansi built Viz.ai from a Stanford dorm-room insight into a platform covering nearly 2,000 U.S. hospitals and 230 million lives, reducing stroke diagnostic timelines by more than an hour - one patient at a time, every ten seconds.
Paxton Maeder-York is the founder of Alife Health, an AI platform for IVF clinics that has raised $31.5M and raised the standard for data-driven fertility care. A Harvard-trained biomedical engineer and MBA, he previously helped build surgical robotics at Auris Health (acquired by J&J for $3.4B) and worked in product at Google X. In 2020, driven in part by the fact that his younger brother is an IVF baby, he founded Alife to apply machine learning to embryo selection, hormone dosing, and lab scheduling. By 2024 the company had launched five products, earned recognition from Fast Company and the World Economic Forum, and achieved a leadership transition - Paxton stepping into a board role as Melissa Teran took the CEO seat.